###begin article-title 0
Somatostatin Secreted by Islet delta-Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function
###end article-title 0
###begin p 1
###xml 45 73 45 73 <email xmlns:xlink="http://www.w3.org/1999/xlink">astrid.hauge_evans@kcl.ac.uk</email>
Corresponding author: Astrid C. Hauge-Evans, astrid.hauge_evans@kcl.ac.uk
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 391 394 369 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 394 397 372 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
OBJECTIVE- Somatostatin (SST) is secreted by islet delta-cells and by extraislet neuroendocrine cells. SST receptors have been identified on alpha- and beta-cells, and exogenous SST inhibits insulin and glucagon secretion, consistent with a role for SST in regulating alpha- and beta-cell function. However, the specific intraislet function of delta-cell SST remains uncertain. We have used Sst-/- mice to investigate the role of delta-cell SST in the regulation of insulin and glucagon secretion in vitro and in vivo.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 152 155 152 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS- Islet morphology was assessed by histological analysis. Hormone levels were measured by radioimmunoassay in control and Sst-/- mice in vivo and from isolated islets in vitro.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 293 296 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 374 377 374 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 377 380 377 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 623 626 623 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 626 629 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 720 723 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 723 726 723 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
RESULTS- Islet size and organization did not differ between Sst-/- and control islets, nor did islet glucagon or insulin content. Sst-/- mice showed enhanced insulin and glucagon secretory responses in vivo. In vitro stimulus-induced insulin and glucagon secretion was enhanced from perifused Sst-/- islets compared with control islets and was inhibited by exogenous SST in Sst-/- but not control islets. No difference in the switch-off rate of glucose-stimulated insulin secretion was observed between genotypes, but the cholinergic agonist carbamylcholine enhanced glucose-induced insulin secretion to a lesser extent in Sst-/- islets compared with controls. Glucose suppressed glucagon secretion from control but not Sst-/- islets.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS- We suggest that delta-cell SST exerts a tonic inhibitory influence on insulin and glucagon secretion, which may facilitate the islet response to cholinergic activation. In addition, delta-cell SST is implicated in the nutrient-induced suppression of glucagon secretion.
###end p 6
###begin p 7
Published ahead of print at  on 4 November 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 727 728 698 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 820 821 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
Islets of Langerhans are heterogeneous cell aggregates containing beta-, alpha-, delta-, and PP cells, which secrete insulin, glucagon, somatostatin (SST), and pancreatic polypeptide, respectively. The different cell types within the islet are affected by changes in the extracellular glucose concentration. Thus, elevations in circulating glucose stimulate insulin secretion from islet beta-cells and inhibit glucagon secretion from alpha-cells as part of the reciprocal regulation of blood glucose by insulin and glucagon. SST secretion from islet delta-cells is also stimulated by increased extracellular glucose, although the threshold concentration for delta-cells to respond to glucose is lower than that for beta-cells (1), and the ionic events in stimulus-response coupling differ between beta- and delta-cells (2).
###end p 9
###begin p 10
###xml 106 107 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 184 185 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 383 384 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 385 386 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 590 592 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 593 595 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 712 713 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 714 716 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 717 719 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 868 869 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 1080 1082 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 1083 1085 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 1256 1258 1229 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 1338 1340 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1419 1421 1385 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 1581 1583 1547 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 1584 1586 1550 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 1720 1722 1686 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 1723 1725 1689 1691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 1726 1728 1692 1694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 1847 1849 1813 1815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 1631 1635 <span type="species:ncbi:10090">mice</span>
###xml 1810 1815 <span type="species:ncbi:10090">mouse</span>
Rodent islets have a defined architecture with a beta-cell core surrounded by a mantle of non-beta-cells (3), whereas human islets do not show such pronounced anatomical subdivisions (4). The anatomical organization of islets is important for their correct functioning, and there is much evidence to suggest that cell-cell interactions within islets are crucial for normal function (5-9). Interactions between islet beta-cells have been investigated extensively, and we have previously demonstrated the importance of homotypic beta-cell interactions in the regulation of insulin secretion (10,11). Similarly, there have been numerous studies of possible interactions between alpha- and beta-cells within islets (9,12-15). Less attention has been paid to the possible intraislet roles of delta-cell-derived SST. delta-Cells comprise 5-10% of the islet endocrine cells (3), but the peptide hormone SST is also synthesized and secreted by neuroendocrine cells in the central nervous system and the gastrointestinal system, and the latter is the major contributor to circulating SST (16,17). SST often acts as an inhibitory regulator of endocrine systems, for example, as a hypothalamic factor to suppress growth hormone secretion from the anterior pituitary (18), or as a local inhibitor of the release of gastrointestinal peptide hormones (19). SST receptors (SSTR1-5) have been identified on both alpha- and beta-cells (20), and exogenously administered SST or SST analogs inhibit glucose-induced insulin secretion and arginine-induced glucagon secretion both in vitro and in vivo (21-24). In addition, studies using SSTR-deficient mice (SSTR1, -2, or -5) revealed changes in both basal and stimulated insulin secretion (21,25,26). However, studies using SSTR knockout models are difficult to interpret because mouse islets express all five SSTRs (20) and reduced expression of one receptor subtype may be compensated for by the overexpression of another. Therefore, although current data are consistent with a negative regulatory role for SST in islet secretory function, it is unclear whether this effect can be ascribed to circulating SST or to locally released delta-cell SST.
###end p 10
###begin p 11
###xml 418 421 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SST</italic>
###xml 463 465 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 379 384 <span type="species:ncbi:10090">mouse</span>
The study of delta-cell function within islets is complicated by the possibility of multiple heterotypic interactions between islet cell types in experiments using intact primary islets. Studies of islet SST have also been hampered by the lack of selective and potent SST receptor antagonists. To investigate the role of locally released delta-cell SST, we have therefore used a mouse model in which disruption of the SST gene produced a SST-deficient phenotype (27). Our results suggest that locally released delta-cell SST exerts a tonic inhibitory influence on insulin and glucagon secretion and that this inhibitory effect of delta-cell SST may be involved in facilitating the insulin secretory response to cholinergic activation and the nutrient-induced suppression of glucagon secretion.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin p 13
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 250 253 250 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 253 256 253 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
Sst-/- mice on a C57BL/6J background were generated as described previously (27) and subsequently rederived onto a CBA/Ca x C57BL/10 F1 background by backcrossing to CBA/Ca x C57BL/10 F1 mice for 10 generations, followed by intercrossing to generate Sst-/- mice on a mixed CBA/Ca x C57BL/10 F1 background. Age-matched CBA/Ca x C57BL/10 F1 mice served as controls.
###end p 13
###begin title 14
Islet isolation.
###end title 14
###begin p 15
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 272 273 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Islets from 8- to 12-week-old female Sst-/- or control mice were isolated by collagenase digestion (1 mg/ml; type XI; Sigma, St. Louis, MO) and separated from exocrine pancreatic tissue on a histopaque gradient (Sigma). Islets were incubated overnight at 37degreesC (5% CO2) in RPMI 1640 (10% FBS, 2% glutamine, 100 units/ml penicillin/0.1 mg/ml streptomycin, and 11 mmol/l glucose) before experiments.
###end p 15
###begin title 16
PCR.
###end title 16
###begin p 17
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 210 217 210 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
RNA was extracted from islets using an RNAeasy kit (Qiagen, Sussex, U.K.). Reverse transcription to cDNA and RT-PCR amplification were performed as described previously (28) using the primer sequences shown in Table 1. All reactions were carried out for 40 cycles. Products were separated on agarose gels and visualized by staining with 0.5 mug/ml ethidium bromide.
###end p 17
###begin title 18
Immunohistochemistry and morphometric analysis.
###end title 18
###begin p 19
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 621 626 <span type="species:ncbi:10090">mouse</span>
###xml 1183 1188 <span type="species:ncbi:10090">mouse</span>
An estimate of islet size and number per mm2 pancreas was obtained by morphometric analysis of fixed pancreatic sections labeled for insulin by immunohistochemistry. The entire paraffin-embedded pancreas from each animal was cut into 5-mum sections onto microscope slides and sections selected for staining and morphometry. Sections were systematically sampled throughout the entire pancreas to give 20 sections per animal for analysis. Sections were dewaxed, hydrated, and labeled with a mouse monoclonal antibody to insulin (Sigma), and positive cells were visualized with a peroxidase-conjugated secondary antibody to mouse IgG and diaminobenzidine as substrate. Sections were counterstained with hematoxylin, and digital images of sections were used for image analysis. Diameters of islets and area of insulin- and glucagon-labeled cells within islets on each section were measured with the aid of image analysis software (ImageJ). Numbers of islets, defined as clusters of five or more beta-cells on the section, were determined relative to pancreatic area. For assessment of the organization of alpha- and beta-cells within the islets, 10 sections per animal were labeled with mouse monoclonal antibodies to glucagon (Sigma) or insulin, respectively, and positive cells were visualized as described above.
###end p 19
###begin title 20
Insulin and glucagon secretion
###end title 20
###begin title 21
In vivo studies.
###end title 21
###begin p 22
###xml 154 156 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 163 165 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 361 367 359 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 530 536 528 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
Eight- to 12-week-old female mice were fasted overnight before the experiments. The animals were anesthetized with sodium pentobarbital (667 mug . 100 mul-1 . 10 g-1 mouse i.p.), and a cannula was inserted into the jugular vein. Glucose (0.5 g/kg) or arginine (0.25 g/kg) was injected, and blood samples were withdrawn at time points indicated in the legend of Fig. 2. For insulin clearance tests, nonfasted mice were injected intravenously with 0.4 unit/kg insulin, and blood samples were withdrawn as indicated in the legend of Fig. 2. Samples were centrifuged, and blood glucose was measured in the plasma using a glucose analyzer (Analox).
###end p 22
###begin title 23
In vitro studies.
###end title 23
###begin p 24
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 281 283 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
For measuring the dynamics of insulin or glucagon release, islets were transferred into chambers of a temperature-controlled multichannel perifusion system as described previously (29) and perifused for 70 min at 37degreesC with a bicarbonate-buffered physiological salt solution (30) containing 2 mmol/l glucose. The tissue was subsequently perifused (0.5 ml/min) with salt solution containing agents of interest, and fractions were collected at 2-min intervals or as indicated on graphs. For static secretion experiments, islets were preincubated for 60 min in buffer containing 2 mmol/l glucose (or 1 mmol/l for SST secretion experiments), after which batches of 15 islets were incubated for 60 min in 0.5-ml salt solution containing agents of interest. The SST 14 isoform (SST-14; St. Helens, Bachem, U.K.) was used as an exogenous source of SST. For assessment of islet hormone content, islets were pelleted by centrifugation, washed with PBS, lysed in acidified ethanol, and sonicated.
###end p 24
###begin title 25
Hormone immunoassays.
###end title 25
###begin p 26
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 292 296 <span type="species:ncbi:9319">Euro</span>
Insulin and glucagon content of incubation medium and islet extracts and insulin content of plasma samples were assessed by radioimmunoassay (RIA) using in-house assays, as described previously (31,32). SST and plasma glucagon levels were measured using commercially available RIA kits (SST: Euro-Diagnostica, Malmo, Sweden; Glucagon: Linco, St. Charles, MO).
###end p 26
###begin title 27
Data analysis.
###end title 27
###begin p 28
###xml 78 79 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 377 378 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data are expressed as means +/- SE and analyzed statistically using Student's t test, one- or two-way ANOVA, and Bonferroni's multiple comparisons test, as appropriate. For statistical analysis of dynamic hormone release, data were expressed as the area under the curve after subtraction of basal secretion values. Differences between treatments were considered significant at P < 0.05.
###end p 28
###begin title 29
RESULTS
###end title 29
###begin title 30
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Phenotypic characterization of control and Sst-/- mice, pancreata, and islets.
###end title 30
###begin p 31
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 157 160 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 160 163 156 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 177 178 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 184 185 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 206 209 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 209 212 205 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 354 357 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 357 360 349 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 374 375 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 385 386 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 502 505 494 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 505 508 497 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 529 530 521 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 523 530 515 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 532 533 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 670 673 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 673 676 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 715 718 704 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 718 721 707 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 737 738 724 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 785 786 772 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 828 829 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 874 875 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 877 880 862 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 880 883 865 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 902 903 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 909 910 892 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 997 1000 971 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1000 1003 974 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1022 1023 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1071 1072 1043 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1192 1195 1157 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1195 1198 1160 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1234 1237 1199 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1237 1240 1202 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1362 1368 1320 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
There were no significant differences in growth or body weight in the Sst-/- female mice versus controls at the ages studied (20 +/- 0.5 vs. 20.9 +/- 0.5 g, Sst-/- vs. control, n = 6, P > 0.2), nor did the Sst-/- animals show any overt behavioral dissimilarities or any differences in resting normoglycemia (8.1 +/- 0.28 vs. 7.4 +/- 0.14 mmol/l glucose, Sst-/- vs. control, n = 36-41, P > 0.2). Insulin tolerance tests showed no differences in sensitivity or maximal glucose suppression between female Sst-/- and controls (Fig. 2C; P > 0.2). Histological analysis of pancreatic sections found no significant differences in the size distribution of islets in control and Sst-/- pancreata (control, 97.2 +/- 3.5 mum; Sst-/-, 95.6 +/- 4.7, n = 88-217 islets from three animals per group, P > 0.2) nor in the number of islets per mm2 pancreas (control, 0.739 +/- 0.054 islets/mm2; Sst-/-, 0.617 +/- 0.064, n = 3, P > 0.2). Furthermore, the ratio of alpha- to beta-cell area (control, 0.267 +/- 0.031; Sst-/-, 0.282 +/- 0.048, n = 32-34 sections from three animals per group, P > 0.2) and the cellular organization of alpha- and beta-cells within the islet were similar in islets from control and Sst-/- animals. Thus, in both control and Sst-/- islets, glucagon-positive alpha-cells were located primarily at the periphery, whereas beta-cells formed a central core (Fig. 1).
###end p 31
###begin title 32
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
In vivo islet hormone secretion from control and Sst-/- mice.
###end title 32
###begin p 33
###xml 275 281 275 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 283 284 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 359 362 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 362 365 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 464 465 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 458 465 458 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 501 508 501 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 510 511 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 610 613 610 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 613 616 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
To assess the importance of SST in regulating islet hormone release, we initially examined the in vivo islet hormone secretory responses in female mice in the presence or absence of endogenous SST. No differences were detected in basal plasma levels of insulin and glucagon (Fig. 2; P > 0.2), but plasma levels of both hormones were significantly elevated in Sst-/- mice when compared with control mice after intravenous administration of glucose (0.5 g/kg; Fig. 2A; P < 0.01) or arginine (0.25 g/kg; Fig. 2B; P < 0.001), respectively. In separate experiments, plasma insulin levels were also enhanced in male Sst-/- mice compared with control animals in response to glucose (data not shown).
###end p 33
###begin title 34
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
In vitro hormone secretion from control and Sst-/- islets.
###end title 34
###begin p 35
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 255 258 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 258 261 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 292 298 288 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
###xml 397 400 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 400 403 396 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 418 421 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;C</italic>
###xml 412 421 408 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A&#8211;C</italic></xref>
###xml 423 424 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 521 524 517 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 524 527 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 542 545 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;D</italic>
###xml 536 545 532 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A&#8211;D</italic></xref>
###xml 554 557 550 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 557 560 553 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 738 739 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 758 759 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 921 924 915 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 924 927 918 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 943 944 935 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 950 951 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1004 1007 994 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1007 1010 997 1000 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1025 1026 1013 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1032 1033 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1227 1228 1215 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1221 1228 1209 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 1281 1282 1269 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1275 1282 1263 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1317 1320 1305 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1320 1323 1308 1311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1606 1607 1594 1595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1624 1625 1612 1613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1618 1625 1606 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 1627 1630 1615 1618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1630 1633 1618 1621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1647 1648 1635 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1737 1740 1725 1728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1740 1743 1728 1731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1956 1957 1940 1941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1950 1957 1934 1941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>E</italic></xref>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
To determine whether the enhanced secretory responses in Sst-/- mice could be attributable to a specific lack of delta-cell SST rather than a global absence of circulating SST, in vitro secretion studies were carried out using islets isolated from female Sst-/- and control mice, as shown in Fig. 3. There was no significant difference between the basal rate of hormone secretion from control and Sst-/- islets (Fig. 3A-C; P > 0.2), whereas stimulus-induced insulin and glucagon release was significantly enhanced in the Sst-/- islets (Fig. 3A-D). Thus, Sst-/- islets showed approximately twofold greater insulin and glucagon secretory responses to elevations in glucose and arginine, respectively, compared with control islets (glucose, P < 0.05; arginine, P < 0.001). The augmented secretory responses did not reflect increased islet hormone content because the content of both insulin (control, 66.0 +/- 8.6 ng/islet; Sst-/-, 50.0 +/- 7.2, n = 6, P > 0.1) and glucagon (control, 3.5 +/- 0.5 ng/islet; Sst-/-, 2.8 +/- 0.5, n = 7, P > 0.1) did not differ significantly between genotypes. As a consequence, the differences in secretory responses between genotypes were observed whether secretion was expressed as a rate (Fig. 3A) or as a percentage of total insulin content (Fig. 3B). Enhanced insulin secretion from Sst-/- islets was not dependent on a nutrient stimulus, because similar effects were observed when secretion was initiated by the sulfonylurea tolbutamide, which bypasses glucose transport and metabolism and stimulates insulin secretion by direct effects on plasma membrane ATP-sensitive K+ channels (Fig. 3D; Sst-/- vs. control; P < 0.01). Thus, the first-phase of tolbutamide-induced insulin secretion was improved in Sst-/- islets compared with control islets. Parallel experiments using control islets demonstrated that delta-cells also responded to the secretagogues, which stimulate insulin and glucagon secretion, as shown in Fig. 3E. Accordingly, glucose, tolbutamide, and arginine all caused significant increases in SST secretion from islets in vitro by 4-, 4.5-, and 2-fold, respectively.
###end p 35
###begin p 36
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 107 110 107 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 119 126 119 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 227 228 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 221 228 220 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 249 250 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 243 250 242 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 283 284 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 359 362 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 362 365 361 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 380 381 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 386 387 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 374 387 373 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic> and <italic>B</italic></xref>
###xml 389 390 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
RT-PCR measurements confirmed the expression of mRNAs for SST receptor subtypes 1-5 in both control and Sst-/- islets (Table 1). Exogenous SST (1 mumol/l) had no significant effect in vitro on stimulus-dependent insulin (Fig. 4A) or glucagon (Fig. 4B) secretion from control islets (P > 0.2) but exerted a marked inhibition of secretion of both hormones from Sst-/- islets (Fig. 4A and B; P < 0.001).
###end p 36
###begin title 37
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
Insulin secretion from control and Sst-/- islets after removal of glucose stimulus.
###end title 37
###begin p 38
###xml 209 215 205 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 333 336 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 336 339 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 383 384 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 377 384 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 652 653 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 646 653 642 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
To investigate whether delta-cell SST facilitates the rapid cessation of insulin secretion when normoglycemia is achieved, we measured the rate of insulin secretion from perifused islets in vitro. As shown in Fig. 5, the rate at which insulin secretion declined to basal levels on removal of glucose (20 mmol/l) was not decreased in Sst-/- islets compared with control islets (Fig. 5A). Similarly, no differences in the switch-off rate of insulin secretion were detected when insulin secretion was expressed as a percentage of stimulated response, to take into account the different magnitude of glucose-induced stimulation in the two genotypes (Fig. 5B).
###end p 38
###begin title 39
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
Parasympathetic stimulation of insulin secretion from control and Sst-/- islets.
###end title 39
###begin p 40
###xml 8 9 8 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 0 9 0 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Figure 3<italic>E</italic></xref>
###xml 247 248 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 253 254 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 241 254 233 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic> and <italic>B</italic></xref>
###xml 421 422 413 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 438 439 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 432 439 424 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 514 515 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 530 531 522 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 524 531 516 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 674 677 666 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 677 680 669 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 707 708 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 701 708 693 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 733 736 725 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 736 739 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 834 835 826 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 828 835 820 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 981 984 973 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 984 987 976 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1111 1112 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1105 1112 1097 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>D</italic></xref>
Figure 3E shows that glucose, arginine, and tolbutamide all stimulated SST secretion from delta-cells, consistent with enhanced insulin and glucagon release in response to these stimuli in the absence of delta-cell SST. However, as shown in Fig. 6A and B, activation of islet cholinergic receptors had opposite effects on insulin and SST secretion, inducing the expected enhancement of glucose-induced insulin secretion (P < 0.001; Fig. 6A) while causing a concomitant inhibition of glucose-induced SST secretion (P < 0.01; Fig. 6B). These observations are consistent with the effects of carbamylcholine (CCh), an acetylcholine analog, on insulin secretion from control and Sst-/- islets, as shown in Fig. 6C. Thus, both control and Sst-/- islets showed an amplification of glucose-induced insulin secretion in response to CCh (Fig. 6C) with no detectable differences in the rate of onset of CCh-induced insulin secretion. However, the extra magnitude of the secretory response of Sst-/- islets to CCh was less than that of control islets, when compared with the glucose-induced secretory response alone (Fig. 6D).
###end p 40
###begin title 41
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 64 67 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
Lack of glucose-induced suppression of glucagon secretion in Sst-/- islets.
###end title 41
###begin p 42
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 252 255 248 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 255 258 251 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 267 273 263 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7</xref>
###xml 338 339 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 344 345 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 332 345 328 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>A</italic> and <italic>C</italic></xref>
###xml 371 372 367 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 377 378 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 365 378 361 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>C</italic> and <italic>D</italic></xref>
###xml 461 462 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 453 462 449 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Figure 7<italic>B</italic></xref>
###xml 547 548 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 541 548 537 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>A</italic></xref>
Our studies using Sst-/- islets also revealed an important role for delta-cell SST in the inhibition of glucagon secretion in response to increases in plasma glucose. Thus, glucose-induced suppression of glucagon secretion in vitro was not detected in Sst-/- islets (Fig. 7), although it was present in control islets at both high (Fig. 7A and C) and intermediate (Fig. 7C and D) glucose concentrations in both static and dynamic secretion experiments. Figure 7B shows the release of insulin in response to glucose in the same experiment as Fig. 7A.
###end p 42
###begin title 43
DISCUSSION
###end title 43
###begin p 44
###xml 202 205 198 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 205 208 201 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 781 784 766 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 778 784 763 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst<sup>&#8722;/&#8722;</sup></italic>
###xml 1144 1147 1125 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1147 1150 1128 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1757 1758 1727 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 1759 1761 1729 1731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 1762 1764 1732 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 2152 2155 2100 2103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 2155 2158 2103 2106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2272 2275 2220 2223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 2275 2278 2223 2226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2384 2385 2325 2326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 2386 2388 2327 2329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 2627 2629 2564 2566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 3058 3060 2958 2960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 3061 3063 2961 2963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 3146 3148 3039 3041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 3239 3241 3132 3134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 3242 3244 3135 3137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 3459 3462 3352 3355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 3462 3465 3355 3358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 3544 3545 3437 3438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 2279 2283 <span type="species:ncbi:10090">mice</span>
Although SST is acknowledged as an inhibitor of insulin and glucagon secretion, the physiological relevance of delta-cell SST remains unknown. Our in vivo data showing that the global absence of SST in Sst-/- mice resulted in increased glucagon and insulin secretion in response to nutrient stimuli confirmed the importance of SST as a negative regulator of islet alpha- and beta-cell function but did not identify delta-cells as the source of that SST. However, in our in vitro studies, the isolated islets were removed from neural, neuroendocrine, and gastrointestinal sources of SST, and this enabled us to focus on the functional consequences of an absence of islet SST. Overall, the lack of any significant differences in islet size, hormone content, or morphology between Sst-/- and control islets suggested that the observed differences in hormone secretion are most likely due to the absence of SST. Consequently, our in vitro studies demonstrated that the lack of locally released delta-cell SST had a profound effect on both insulin and glucagon secretion, leading to enhanced levels of stimulus-induced release of both hormones from Sst-/- islets compared with control islets without affecting basal levels of hormone secretion. Thus, although we cannot rule out an effect of circulating SST of neuroendocrine and/or gastrointestinal origin on islet function in vivo, our in vivo and in vitro studies are consistent with an important role for islet SST in the regulation of beta- and alpha-cell secretory function. Our direct measurements of SST secretion in vitro also confirmed previous reports that some insulin and/or glucagon secretagogues, including glucose, arginine, and tolbutamide, also stimulate the secretion of SST from delta-cells (1,33,34). Taken together, our data are consistent with a model in which SST released from islet delta-cells exerts direct, tonic inhibitory effects on glucagon and insulin secretion from neighboring alpha- and beta-cells. Under resting conditions, the quiescent delta-cells exert little or no influence on the neighboring alpha- and beta-cells, and no difference is observed between control and Sst-/- islets with regard to basal secretion nor in the basal levels of plasma insulin and glucagon between control and Sst-/- mice. However, exposure of islets to glucose or sulfonylureas activates both beta-cells and delta-cells (1,34), which initiates an insulin secretory response and simultaneously causes the local release of SST to limit that response. Similarly, the stimulation of glucagon secretion by arginine is accompanied by both the activation of delta-cells (33) and the intraislet release of SST to limit the alpha-cell secretory response. In this way, both in vitro and in vivo results are consistent with delta-cell SST exerting an inhibitory paracrine influence on islet alpha- and beta-cells. The route through which delta-cell SST reaches alpha- and beta-cells is uncertain; early reports on islet blood flow do not support a vascular route from delta-cells to alpha- and beta-cells (35,36), although other data do imply a direct vascular route from delta- to beta-cells (37). Alternatively, SST delivery may be mediated by diffusion via interstitial compartments (38,39) independent of islet vasculature. An extensive exploration of the mechanism of action of islet SST was beyond the scope of this study, but it is of interest that the first phase of insulin release was enhanced in Sst-/- islets, perhaps suggesting a direct or indirect effect via the ATP-sensitive K+ channels.
###end p 44
###begin p 45
###xml 313 316 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 316 319 312 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 638 641 630 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 641 644 633 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 860 862 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 1254 1256 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
The proposed model of paracrine regulation of islet function by delta-cell SST is further supported by our observations that exogenous SST had no significant effect in vitro on stimulus-dependent insulin or glucagon secretion from control islets but exerted a marked inhibition of secretion of both hormones from Sst-/- islets. The lack of effect of exogenous SST on hormone secretion from control islets is consistent with a tonic inhibition by endogenous delta-cell SST of islet hormone secretion that cannot be further repressed by the provision of exogenous SST. In contrast, the absence of this inhibitory input by endogenous SST in Sst-/- islets reveals the ability of exogenous SST to inhibit both insulin and glucagon secretion. An experimental model in which delta-cell SST prevents further inhibition by exogenous SST would account for the reported (22) and anecdotal variability of the effects of SST on islet hormone secretion in studies using isolated islets, because the inhibition of hormone secretion by exogenous SST will be inversely related to the content of endogenous SST in islet delta-cells, which are easily lost or damaged during islet isolation because of their location on the periphery of the islets, particularly in rodents (40).
###end p 45
###begin p 46
###xml 529 531 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
###xml 671 674 656 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 674 677 659 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
The intraislet inhibitory input from delta-cells is likely to be involved in fine-tuning beta- and alpha-cell responses to external signals: The regulation of homeostatic responses through a balance between excitatory and inhibitory inputs has many parallels in physiology and would enable the precise degree of control required for the endocrine regulation of plasma glucose within strict limits. We considered first whether delta-cell SST was used to ensure the rapid cessation of insulin secretion on achieving normoglycemia (41). However, our in vitro measurements demonstrated that the rate of decline of insulin secretion on removal of glucose was not decreased in Sst-/- islets compared with control islets, suggesting that delta-cell SST does not regulate the termination of insulin secretory responses to glucose.
###end p 46
###begin p 47
###xml 317 319 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r42">42</xref>
###xml 320 322 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r43">43</xref>
###xml 1063 1066 1048 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1066 1069 1051 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1129 1132 1114 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1132 1135 1117 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1348 1351 1333 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1351 1354 1336 1339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
Although many insulin secretagogues also stimulate SST release from delta-cells, we found that the receptor-operated cholinergic agonist CCh enhanced glucose-induced insulin secretion but caused a marked inhibition of glucose-induced SST secretion from control islets, as has been suggested by some previous studies (42,43). The proposed model of paracrine regulation of insulin secretion by delta-cell SST would therefore predict that activation of islet cholinergic receptors in the presence of stimulatory concentrations of glucose enhances insulin secretion both by direct stimulatory effects on beta-cells and by relieving the inhibitory delta-cell input as a consequence of the CCh-mediated inhibition of glucose-induced SST secretion. In this model, the effect of cholinergic activation to enhance a maximum glucose-induced insulin secretory response will be reduced in the absence of SST because the tonic inhibitory effect of SST on glucose-induced insulin secretion will be absent and will therefore not be alleviated by CCh. Our in vitro studies using Sst-/- islets concur with this prediction. Thus, both control and Sst-/- islets showed an amplification of glucose-induced insulin secretion in response to CCh to achieve similar maximum rates of secretion. However, the extent of the CCh-induced component of the secretory response in Sst-/- islets was much less than that of control islets when compared with their maximum responses to glucose alone. The overall effect of the presence of delta-cell SST was therefore to enhance the amplitude of the CCh-induced component of the secretory response. We propose that one physiological function of the tonic inhibitory input of delta-cell SST on islet beta-cells is to ensure that a relatively transient stimulatory input via parasympathetic activation results in large changes in the overall mass of insulin secreted for the duration of the cholinergic activation.
###end p 47
###begin p 48
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 350 351 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 352 354 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 437 439 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 444 446 429 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 448 450 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 482 484 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 512 515 493 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 515 518 496 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1061 1062 1035 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
Finally, our in vitro experiments using Sst-/- islets revealed a further role for delta-cell SST in the inhibition of glucagon secretion in response to increases in extracellular glucose. Various mechanisms have been proposed for the inhibitory effects of glucose on alpha-cell secretory function, including direct effects of glucose on alpha-cells (1,44) or paracrine inhibitory effects of beta-cell secretory products such as insulin (14), Zn2+ (13), and gamma-aminobutyric acid (45). In our experiments using Sst-/- islets, glucose-induced suppression of glucagon secretion was not detected, although it was observed in control islets over a range of glucose concentrations, suggesting that glucose-induced SST release is a major contributor to the inhibitory effects of glucose on islet alpha-cells. Consistent with this, it has been reported recently that the concentration dependency of glucose-induced inhibition of glucagon secretion correlates closely to that for the stimulation of SST secretion but is dissociated from that for beta-cell activation (1). Our results therefore suggest an important role for delta-cell SST in the regulation of glucagon secretion by glucose but do not rule out the involvement of other regulatory mechanisms.
###end p 48
###begin p 49
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 655 657 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r46">46</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
In summary, our studies using Sst-/- mice support important intraislet paracrine roles for delta-cell-derived SST in the regulation of islet hormone secretion. Intraislet SST exerts tonic inhibitory effects on stimulus-induced insulin and glucagon secretion, which may be important in regulating responses to receptor-operated stimuli, such as cholinergic agonists. Our studies also suggest that delta-cell SST also plays a significant role in the suppression of glucagon secretion by glucose. These observations highlight the importance of delta-cells in the normal function of the endocrine pancreas and suggest that delta-cell dysfunction in diabetes (46) may have important consequences for hormone secretion from islet alpha- and beta-cells.
###end p 49
###begin p 50
A.C.H.-E. and C.C.R. were funded by Diabetes UK. A.J.K. is a Research Council UK Research Fellow. D.C. has received MRC core funding. I.C.A.F.R. has received MRC core funding.
###end p 50
###begin p 51
No potential conflicts of interest relevant to this article were reported.
###end p 51
###begin p 52
We gratefully acknowledge the assistance of William Jefferson and Dr. Henry Asare-Anane with hormone measurements.
###end p 52
###begin title 53
REFERENCES
###end title 53
###begin p 54
###xml 66 69 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 69 72 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 114 115 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 120 121 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 126 129 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 129 132 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 134 135 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 140 141 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 182 183 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 188 189 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 204 205 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 210 211 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
Intraislet organization of alpha- and beta-cells from control and Sst-/- islets. Consecutive sections of control (A and B) or Sst-/- (C and D) mouse islets were stained for insulin (A and C) or glucagon (B and D), respectively, and are representative of sections from three different animals. (Please see  for a high-quality digital representation of this figure.)
###end p 54
###begin p 55
###xml 40 41 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 227 228 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 256 259 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 259 262 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 410 413 406 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 413 416 409 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 445 446 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 473 476 469 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 476 479 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
Insulin and glucagon secretion in vivo. A: Plasma insulin levels in Sst-/- mice and control mice 0, 2, 5, and 15 min after an intravenous glucose challenge (0.5 g/kg). Points show means +/- SE for four to six separate animals. B: Plasma glucagon levels in Sst-/- mice and control mice 0, 2, and 5 min after injection of intravenous arginine (0.25 g/kg). Points show means +/- SE for 5 and 14 separate animals (Sst-/- and control, respectively). C: Plasma glucose levels in Sst-/- mice and control mice 0, 15, 30, 45, and 60 min after injection of intravenous insulin (0.4 units/kg). Points show means +/- SE for five separate animals.
###end p 55
###begin p 56
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SST<sup>&#8722;/&#8722;</sup></italic>
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 268 269 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 364 365 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 440 441 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 501 504 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 504 507 502 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 561 562 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 666 667 662 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 789 792 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 792 795 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 849 850 842 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 876 877 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 993 994 984 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1059 1060 1050 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1071 1072 1062 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Hormone secretion from control and SST-/- islets. A: Insulin secretion from control and Sst-/- mouse islets at a substimulatory concentration of glucose (2 mmol/l G, 0-10 min) and at a stimulatory concentration of glucose (bar, 20 mmol/l G). Points show means +/- SE, n = 7-8 separate perifusion channels in each experiment, typical of 10 separate experiments. In B, the same results are expressed as a percentage of total insulin content. C: Arginine-induced (20 mmol/l, bar) glucagon secretion from Sst-/- islets and control islets. Points show means +/- SE, n = 4 perifusion channels. Where no error bars are shown, they are smaller than the size of the symbols. D: Insulin secretory responses to the sulfonylurea tolbutamide (100 mumol/l, bar) in the presence of 2 mmol/l glucose from Sst-/- islets and control islets. Points show means +/- SE, n = 4 perifusion channels. E: SST secretion from control islets in response to glucose, tolbutamide, and arginine. Bars represent means +/- SE, n = 8-9 in one experiment typical of three separate experiments. *P < 0.05, **P < 0.01 vs. 1 mmol/l glucose alone.
###end p 56
###begin p 57
###xml 164 165 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 227 228 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 254 257 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 257 260 256 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 295 296 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 416 417 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 426 427 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Inhibition of insulin and glucagon secretion by exogenous SST. Effect of exogenous SST (1 mumol/l) on dynamic glucose-induced insulin secretion (20 mmol/l G, bar) (A) and static arginine-induced (20 mmol/l) glucagon secretion (B) from control islets and Sst-/- islets. Points show means +/- SE, n = 4 separate perifusion channels in each experiment, typical of six separate experiments. Bars represent means +/- SE, n = 6. ***P < 0.001 vs. arginine (Arg) alone.
###end p 57
###begin p 58
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 167 170 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 251 252 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 425 426 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Rate of decline in insulin secretion from control and Sst-/- islets after removal of glucose stimulus. A: Glucose-induced (20 mmol/l G, bar) insulin secretion from Sst-/- islets and control islets is reversed to basal levels upon removal of stimulus. B: The decline in insulin secretion from stimulated to basal levels is expressed as percent stimulated insulin secretion before removal of glucose. Points show means +/- SE, n = 4 separate perifusion channels.
###end p 58
###begin p 59
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 97 98 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 253 254 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 320 321 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 369 370 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 397 398 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 438 439 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 444 445 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 476 477 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 592 595 563 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 595 598 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 752 753 721 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 842 843 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
Parasympathetic stimulation of insulin secretion from control and Sst-/- islets. Static insulin (A) and SST secretion (B) from control islets in response to glucose (20 mmol/l) and the cholinergic agonist CCh (500 mumol/l). Bars represent means +/- SE, n = 8-9 in one experiment typical of three separate experiments. **P < 0.01 vs. 1 mmol/l glucose alone, daggerdaggerP < 0.01, daggerdaggerdaggerP > 0.001 vs. 20 mmol/l glucose. Data in A and B are from the same experiment. C: Effect of CCh (500 mumol/l) on dynamic glucose-induced (20 mmol/l G, bar) insulin secretion from control (o) and Sst-/- (*) islets. Fractions were collected every 1 min between 10 and 30 min and 50 and 60 min and every 30 s between 30 and 50 min. Points show means +/- SE, n = 3 perifusion channels in one experiment representative of three separate experiments. D: The effect of CCh is expressed as a percentage stimulation of the glucose-induced (20 mmol/l) secretory response (mean amplitude of secretion at time points 31-40 min expressed as a percentage of mean amplitude at 21-30 min).
###end p 59
###begin p 60
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 171 174 166 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 174 177 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 267 268 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 277 278 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 308 309 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 373 374 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 386 387 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 479 482 446 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 482 485 449 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 606 607 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 610 611 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 665 668 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 668 671 630 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 914 915 848 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 924 925 858 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 955 956 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1053 1056 987 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 1056 1059 990 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1148 1149 1080 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1185 1186 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Glucose-induced suppression of glucagon secretion requires SST. A: Effect of high glucose concentration (20 mmol/l) on glucagon secretion from control islets (square) and Sst-/- islets (blacksquare, square, filled) in static incubations. Bars represent means +/- SE, n = 5-7. *P < 0.05 vs. 2 mmol/l glucose. B: Glucose-induced insulin secretion from the same experiment. **P < 0.01, ***P < 0.001 vs. 2 mmol/l glucose. There was no significant increase in glucagon secretion from Sst-/- islets in response to glucose in seven separate experiments, although in three of these, secretion appeared higher (see A). C: Glucagon secretion from control islets (square) and Sst-/- islets (blacksquare, square, filled) in response to increasing glucose concentrations. Islets were preincubated in the absence of glucose for 1 h before exposure to the glucose concentrations shown in the figure. Bars represent means +/- SE, n = 5-6. *P < 0.05 vs. 0 mmol/l glucose. D: Effect of 10 mmol/l glucose (G, bar) on dynamic glucagon secretion from control islets (o) and Sst-/- islets (*) preincubated in the absence of glucose for 20 min. Points show means +/- SE, n = 4 perifusion channels. Controls, P < 0.001 for 0 vs. 10 mmol/l glucose mean values.
###end p 60
###begin p 61
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
SST and SSTR1-5 mRNA expression in control and Sst-/- islets
###end p 61
###begin p 62
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 138 141 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 141 144 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 201 204 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sst</italic>
###xml 204 207 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
SST mRNA was detected by RT-PCR in control but not in Sst-/- mouse islet extracts, confirming the absence of endogenous delta-cell SST in Sst-/- mice. SSTR1-5 mRNAs were identified in both control and Sst-/- islet extracts. F, forward primer, R, reverse primer.
###end p 62

